A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EMDA / electromotive drug administration

[Related PubMed/MEDLINE]
Total Number of Papers: 43
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EMDA  (>> Co-occurring Abbreviation)
Long Form:   electromotive drug administration
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Corrigendum to "Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy)" [Pathol. Res. Pract. 213 (2017) 1078-1081]. ---
2018 ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes. HG-NMIBC
2018 Intravesical device-assisted therapiesfor non-muscle-invasive bladder cancer. NMIBC, RITE
2018 Intravesical Electromotive Botulinum Toxin Type "A" Administration for Management of Urinary Incontinence Secondary to Neuropathic Detrusor Overactivity in Children: Long-term Follow-up. BoNTA, NDO
2018 The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration. AUC, CHT, EMDA/MMC, SHGUC
2017 Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy). AUC, CHT, MMC, NHGUC, NMIBC
2017 Intravesical Chemotherapy and Chemohyperthermia in Non-Muscle-Invasive Bladder Cancer; An Overview on Drug Administration Technologies and Pharmacokinetics. RITE
2017 Intravesical electromotive drug administration for non-muscle invasive bladder cancer. BCG, CENTRAL, MEDLINE, EMBASE, CI, CIS, HR, MMC, NMIBC, PD, QoE, RR, TURBT
2016 Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014. NDO
10  2016 Investigation of the mechanisms of action behind Electromotive Drug Administration (EMDA). ---
11  2015 [Non-muscle invasive bladder cancer: safety of postoperative EMDA-assisted instillation of mitomycin]. TURBT
12  2014 Instillation of Hyaluronic Acid via Electromotive Drug Administration Can Improve the Efficacy of Treatment in Patients With Interstitial Cystitis/Painful Bladder Syndrome: A Randomized Prospective Study. BPS/IC, VAS
13  2014 Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease. PD
14  2014 The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer. BCG, CHT, NMIBC
15  2013 [Intravesical therapy with mitomycin through electromotive drug administration]. MMC, NMIBC, TURBT
16  2013 [Second-line intravesical therapy. What is the present role of device-assisted therapy?]. BCG, TCT
17  2013 [The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients]. IC
18  2011 Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. PD, TURBT
19  2011 Intravesical electromotive botulinum toxin type A administration: part I--Experimental study. BTX-A
20  2011 [Therapy-refractory overactive bladder: alternative treatment approaches]. OAB
21  2009 Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity. BC, DF, FDV, IDO, KHQ, MCBC, QOL, SDV, UIC
22  2009 Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer. MMC, NMIBC, PD
23  2008 Electromotive drug administration for treatment of therapy-refractory overactive bladder. ICS
24  2008 Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer. ---
25  2008 [Intravesical Electromotive Drug Administration(EMDA)with Mitomycin-C for non-muscle invasive bladder cancer]. MMC
26  2005 Office bladder distention with electromotive drug administration (EMDA) is equivalent to distention under general anesthesia (GA). GA, GA, IC, OR
27  2005 Pilot study of the feasibility of in-office bladder distention using electromotive drug adminstration (EMDA). IC
28  2004 Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor. ---
29  2004 Transient ischemic attack after electromotive drug administration for chronic non-infectious cystitis: report of two similar cases. TIA
30  2004 [Interstitial cystitis. Current aspects of diagnosis and therapy]. ---
31  2002 Photodynamic therapy for superficial bladder cancer under local anaesthetic. ALA, LA, PD, PDT, TCC
32  1999 Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies. CV, MMC, PD
33  1999 Extraction and determination of oxybutynin in human bladder samples by reversed-phase high-performance liquid chromatography. OXB
34  1999 [Interstitial cystitis: local electromotive drug administration (EMDA)]. ---
35  1998 Electromotive drug administration of lidocaine to anesthetize the bladder before intravesical capsaicin. ---
36  1998 Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: a comparative Phase II study. CR, MMC, TCC
37  1998 Intravesical electromotive drug administration technique: preliminary results and side effects. ---
38  1997 Bladder and urethral anaesthesia with electromotive drug administration (EMDA): a technique for invasive endoscopic procedures. EMDA/LA, TURs
39  1997 Electromotive administration of oxybutynin into the human bladder wall. PD
40  1997 Electromotive delivery of mitomycin C into human bladder wall. MMC
41  1997 Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. ---
42  1997 Intravesical electromotive drug administration for the treatment of non-infectious chronic cystitis. NICC
43  1996 Comparison of electromotive drug administration with ketorolac or with placebo in patients with pain from rheumatic disease: a double-masked study. VAS